| Application | Comment | Organism |
|---|---|---|
| food industry | transglycosylation product maltosyl-alpha-(1->6)-mangiferin shows 5500fold higher aqueous solubility than mangiferin, and both maltosyl-alpha-(1->6)-mangiferin and glucosyl-alpha-(1->6)-mangiferin exhibits similar 1,1-diphenyl-2-picrylhydrazyl free radical scavenging activities compared to mangiferin | Parageobacillus galactosidasius |
| Cloned (Comment) | Organism |
|---|---|
| expression in Escherichia coli | Parageobacillus galactosidasius |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| additional information | addition of Mg2+, K+, or EDTA does not significantly affect the activity | Parageobacillus galactosidasius |
| Organic Solvent | Comment | Organism |
|---|---|---|
| DMSO | 10 %, about 60% residual activity | Parageobacillus galactosidasius |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Parageobacillus galactosidasius | A0A226QRS7 | cf. EC 3.2.1.133 | - |
| Parageobacillus galactosidasius DSM 18751 | A0A226QRS7 | cf. EC 3.2.1.133 | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| beta-cyclodextrin + mangiferin | - |
Parageobacillus galactosidasius | glucosyl-alpha-(1->6)-mangiferin + maltosyl-alpha-(1->6)-mangiferin | - |
? | |
| beta-cyclodextrin + mangiferin | - |
Parageobacillus galactosidasius DSM 18751 | glucosyl-alpha-(1->6)-mangiferin + maltosyl-alpha-(1->6)-mangiferin | - |
? | |
| beta-cyclodextrin + puerarin | - |
Parageobacillus galactosidasius | ? | - |
? | |
| beta-cyclodextrin + puerarin | - |
Parageobacillus galactosidasius DSM 18751 | ? | - |
? |
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 65 | - |
- |
Parageobacillus galactosidasius |
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 7 | - |
- |
Parageobacillus galactosidasius |